Thermo Fisher Scientific CD56 (NCAM) Monoclonal Antibody (TULY56), Brilliant Ultra Violet 805, eBioscience

Thermo Fisher Scientific CD56 (NCAM) Monoclonal Antibody (TULY56), Brilliant Ultra Violet 805, eBioscience

Applications and Tested Dilution

• Application: Flow Cytometry
• Tested Dilution: 5 µL (0.125 µg)/test

Product Specifications

Additional Formats Available

• Alexa Fluor 660, 700
• APC, APC-eFluor 780
• Brilliant UV 395, 563, 661, 737
• Brilliant Violet 421, 605, 650, 711, 786
• eFluor 450, 506
• FITC
• NovaFluor Blue/Red/Yellow series
• PE, PE-Cyanine5, PE-Cyanine7, PE-eFluor 610
• PerCP-eFluor 710
• Super Bright 436, 600, 645, 702, 780
• Custom conjugation available upon request

Product Specific Information

This TULY56 monoclonal antibody reacts with human CD56 (Neural Cell Adhesion Molecule, NCAM), a glycosylated transmembrane molecule expressed by neurons and NK/NKT cells.
TULY56 and CMSSB recognize different epitopes; TULY56 shows better performance after fixation and permeabilization.
Crossreacts with Rhesus macaque.

• Applications Reported: Flow cytometric analysis
• Applications Tested: Pre-diluted and validated for flow cytometry of human peripheral blood cells at 5 µL/test (0.125 µg/test).
• Recommended Cell Range: 10⁵–10⁸ cells/test.
• Fluorochrome: Brilliant Ultra Violet™ 805 (BUV805), emits at 797 nm, UV laser excitation (355 nm).
• Buffer Recommendation: Use Super Bright or Brilliant Stain Buffer to minimize polymer interactions.
• Light Sensitivity: Protect from light to prevent photo-induced oxidation.
• Fixation Compatibility: Stable up to 3 days at 4°C in IC Fixation Buffer or Fix/Lyse Solution. Compatible with short-term methanol fixation (<1 hour).
• Laser Excitation/Emission: 355 nm / 797 nm.

BRILLIANT ULTRA VIOLET™ is a trademark of Becton, Dickinson and Company, used under license. Powered by Sirigen™.

Target Information

CD56 (NCAM) is a transmembrane glycoprotein involved in cell adhesion, migration, and synaptic plasticity.
Expressed in neurons, NK cells, and T cells.
Associated with neuroectodermal-derived tumors (retinoblastoma, medulloblastoma, astrocytoma, neuroblastoma) and neuroendocrine markers.
Altered CD56 function is linked to diseases such as rabies and blastic plasmacytoid dendritic cell neoplasms.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without authorization.

제품 이미지